Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Emerg Infect Dis ; 22(5): 866-70, 2016 May.
Artigo em Inglês | MEDLINE | ID: mdl-27089307

RESUMO

We genetically characterized 32 canine rabies viruses isolated in Mali during 2006-2013 and identified 3 subgroups that belonged to the Africa 2 lineage. We also detected subgroup F rabies virus. This information should be useful for development of mass vaccination campaigns for dogs and eventual large-scale control programs in this country.


Assuntos
Doenças do Cão/epidemiologia , Doenças do Cão/virologia , Vírus da Raiva/classificação , Vírus da Raiva/genética , Raiva/veterinária , Animais , Cães , Geografia , Mali/epidemiologia , Filogenia , Filogeografia , Vigilância em Saúde Pública , RNA Viral
2.
BMC Vet Res ; 5: 19, 2009 May 19.
Artigo em Inglês | MEDLINE | ID: mdl-19454020

RESUMO

BACKGROUND: Since 1954, there have been in excess of 800 cases of rabies as a result of European Bat Lyssaviruses types 1 and 2 (EBLV-1, EBLV-2) infection, mainly in Serotine and Myotis bats respectively. These viruses have rarely been reported to infect humans and terrestrial mammals, as the only exceptions are sheep in Denmark, a stone marten in Germany and a cat in France. The purpose of this study was to investigate the susceptibility of foxes to EBLVs using silver foxes (Vulpes vulpes) as a model. RESULTS: Our experimental studies have shown that the susceptibility of foxes to EBLVs is low by the intramuscular (IM) route, however, animals were sensitive to intracranial (IC) inoculation. Mortality was 100% for both EBLV-1 approximately 4.5 logs) and EBLV-2 (approximately 3.0 logs) delivered by the IC route. Virus dissemination and inflammatory infiltrate in the brain were demonstrated but virus specific neutralising antibody (VNA) was limited (log(ED50) = 0.24-2.23 and 0.95-2.39 respectively for specific EBLV-1 and EBLV-2). Foxes were also susceptible, at a low level, to peripheral (IM) infection approximately 3.0 logs) with EBLV-1 but not EBLV-2. Three out of 21 (14.3%) foxes developed clinical signs between 14 and 24 days post-EBLV-1 infection. None of the animals given EBLV-2 developed clinical disease. CONCLUSION: These data suggest that the chance of a EBLV spill-over from bat to fox is low, but with a greater probability for EBLV-1 than for EBLV-2 and that foxes seem to be able to clear the virus before it reaches the brain and cause a lethal infection.


Assuntos
Raposas , Lyssavirus/classificação , Infecções por Rhabdoviridae/veterinária , Animais , Anticorpos Antivirais/sangue , Lyssavirus/patogenicidade , RNA Viral/isolamento & purificação , Infecções por Rhabdoviridae/virologia , Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...